While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Johnson & Johnson's (JNJ) prostate cancer therapy Erleada outperforms rival treatment from Pfizer (PFE) stellas (ALPMF) in ...

Singlera Genomics and Astellas Pharma presented results during the JSOT 2024 Annual Meeting demonstrating that drug-induced testicular toxicity can be detected using cell-free DNA methylation in ...

Astellas is rolling out its first DTC campaign to raise awareness about an injection that treats geographic atrophy.

PRESS RELEASEOMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate ...

Patient-reported quality of life (QoL) was similar between proton beam therapy (PBT) and intensity-modulated radiation ...

Astellas Pharma is slowing things down in the inaugural consumer-facing marketing blast for eye disease drug Izervay. | ...

The Federal Circuit has vacated a District of Delaware ruling in a patent case which found that patent claims asserted by ...

Drug shortages are becoming more severe around the world.1 The causes of worsening drug shortages in Japan include the impact of a large-scale campaign to switch from brand name to generic drugs and a ...

With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, ...